These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1024 related articles for article (PubMed ID: 16901971)
21. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line. Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406 [TBL] [Abstract][Full Text] [Related]
22. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. Teng J; Wang ZY; Jarrard DF; Bjorling DE Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301 [TBL] [Abstract][Full Text] [Related]
23. ERα/ERβ-directed CBS transcription mediates E2β-stimulated hUAEC H2S production. Bai J; Lechuga TJ; Makhoul J; Yan H; Major C; Hameed A; Chen DB J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36476832 [TBL] [Abstract][Full Text] [Related]
24. Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha. Maruyama S; Fujimoto N; Asano K; Ito A J Steroid Biochem Mol Biol; 2001 Aug; 78(2):177-84. PubMed ID: 11566442 [TBL] [Abstract][Full Text] [Related]
25. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Chang EC; Frasor J; Komm B; Katzenellenbogen BS Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442 [TBL] [Abstract][Full Text] [Related]
26. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells. Pak TR; Chung WC; Lund TD; Hinds LR; Clay CM; Handa RJ Endocrinology; 2005 Jan; 146(1):147-55. PubMed ID: 15471969 [TBL] [Abstract][Full Text] [Related]
27. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue. Evers NM; van de Klundert TM; van Aesch YM; Wang S; de Roos WK; Romano A; de Haan LH; Murk AJ; Ederveen AG; Rietjens IM; Groten JP Toxicol In Vitro; 2013 Sep; 27(6):1753-61. PubMed ID: 23680332 [TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells. Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110 [TBL] [Abstract][Full Text] [Related]
29. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus. Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006 [TBL] [Abstract][Full Text] [Related]
30. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Jiang J; Slivova V; Sliva D Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287 [TBL] [Abstract][Full Text] [Related]
31. A distal estrogen responsive element upstream the cap site of human transthyretin gene is an enhancer-like element upon ERα and/or ERβ transactivation. Martinho A; Santos CR; Gonçalves I Gene; 2013 Sep; 527(2):469-76. PubMed ID: 23860318 [TBL] [Abstract][Full Text] [Related]
32. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531 [TBL] [Abstract][Full Text] [Related]
33. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta. Bhavnani BR; Tam SP; Lu X Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548 [TBL] [Abstract][Full Text] [Related]
34. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex. Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412 [TBL] [Abstract][Full Text] [Related]
35. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells. Caruso JA; Campana R; Wei C; Su CH; Hanks AM; Bornmann WG; Keyomarsi K Cell Cycle; 2014; 13(16):2587-99. PubMed ID: 25486199 [TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells. Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659 [TBL] [Abstract][Full Text] [Related]
37. Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Zhao C; Gao H; Liu Y; Papoutsi Z; Jaffrey S; Gustafsson JA; Dahlman-Wright K Cancer Res; 2010 Jun; 70(12):5174-83. PubMed ID: 20501845 [TBL] [Abstract][Full Text] [Related]
38. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies. Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890 [TBL] [Abstract][Full Text] [Related]
39. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells. Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta? Soldati R; Wargon V; Cerliani JP; Giulianelli S; Vanzulli SI; Gorostiaga MA; Bolado J; do Campo P; Molinolo A; Vollmer G; Lanari C Breast Cancer Res Treat; 2010 Oct; 123(3):709-24. PubMed ID: 20012353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]